CClinicalTrials.gg
Status unknownNCT03320005Updated Oct 24, 2017

EFFECTS OF RESISTANCE TRAINING IN ELDERLY

An interventional study of Resistance training group in Aging Disorder, sponsored by Daysi Tobelem. Status unknown. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2017-10-24.

Sponsored by Daysi Tobelem · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2017), so the status shown — last known as Enrolling by invitation — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Non-randomized
Ages
60 Years and older
Sex
All
01

Study summary

This comes from a non-randomized clinical trial, which aims to check on elderly women the effects of a program of resistance training (TR) in physical performance, in respiratory functional capacity, on health and quality of life.

Read the detailed description

Will be measured the strength of the respiratory muscles (Mip and Mep), peak expiratory flow (Peak-Flow), thoracic movements and abdominal movements, distance traveled in Incremental Shuttle Walk Test, grip strength manual, pulmonary leukocytes, biochemical parameters and indicators of quality of life and physical activity through the WHOQOL-old and IPAQ-short. The data will be tested against the distribution of the Gauss curve, by the shapiro-wilk test and, if they have a normal distribution (parametric) are expressed as mean and standard deviation, if not submit normal (non parametric) distribution will be expressed as median or range interquartílico. The first chance to compare the evolution of the group studied, will be applied to two-way ANOVA. If the distribution is abnormal, it will apply Mann-Whitney test. The multiple regression test will be used to compare the Mip and Mep with variables with the Peak-Flow, Thoracoabdominal mobility, distance traveled, immune competence, physical fitness and quality of life in the groups studied.

02

Conditions studied

  • Aging Disorder

Keywords

  • respiratory performance
  • quality of life
  • physical performance
03

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 60 year old or more
  • Do not have cardiac or respiratory diseases
  • neurological, Musculoskeletal and other diseases preventing the practice of exercises
  • not being a smoker; agree to participate in the study and signed an informed consent (IC); in the last six months preceding the evaluation did not have participated in physical activity program with the aim of improving physical performance.

Exclusion criteria

Exclusion Criteria:

  • Difficult to complete the tasks
  • Acute diseases
  • Refuse to continue the program
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Active comparator
    ResistanceTraining Group

    The RT program has the following features: 05 classes performing two weekly sessions; day shift; sessions with maximum duration of 1 (one) hour; 02 series; 08 to 12 repetitions; interval between sets of 01 to 02 minutes; exercises: bench press, seated leg press 45°, pull forward, Earth, rowing standing calf standing, power lifting, abdominal and development.

    Other: Resistance training group

  • No intervention
    Non training group

    sedentary elderly

Interventions

  • OtherResistance training group

    Resistive exercises for legs and arms

05

What researchers measure

Primary outcomes

  1. Physical performance

    distance traveled on ISWT

    Time frame: Change from Baseline at 24 weeks

Secondary outcomes

  1. quality of life

    quality of life (WHOQOL-old)

    Time frame: Change from Baseline at 24 weeks

  2. respiratory muscle strength

    respiratory pressures

    Time frame: Change from Baseline at 24 weeks

  3. Hand grip

    Hand grip test

    Time frame: Change from Baseline at 24 weeks

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03320005
Lead sponsor
Daysi Tobelem
Responsible party
Daysi Tobelem (professor, University of Nove de Julho) — Sponsor-investigator
First posted
Oct 24, 2017
Start date
Jan 2017
Primary completion
Dec 2017 (estimated)
Completion
Jan 2018 (estimated)
Last update
Oct 24, 2017

Study contacts

Dirceu Costa, PhD
study chair · Nove de Julho University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion